CITATIONS


JOP. J Pancreas (Online) 2005; 6(3):216-230.

Chemoradiation for Ductal Pancreatic Carcinoma: Principles of Combining Chemotherapy with Radiation, Definition of Target Volume and Radiation Dose

Wilkowski R, Thoma M, Weingandt H, Dühmke E, Heinemann V

Clinic for Radiation Oncology and Medical Clinic III, LMU University Hospital Grosshadern. Munich, Germany


Cited by:

4

Goldstein D, Van Hazel G, Walpole E, Underhill C, Kotasek D, Michael M, et al. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer. Br J Cancer 2007; 97(4):464-71. [More details]

3

Kurt E, Kurt M, Kanat O, Cetintas SK, Aygun S, Palazoglu T, et al. Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer. Tumori 2006; 92(6):481-6. [More details]

2

Hassan R, Williams-Gould J, Steinberg SM, Liewehr DJ, Yokokawa J, Tsang KY, et al. Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts. Clin Cancer Res 2006; 12(16):4983-8. [More details]

1

Ask A, Johansson B, Glimelius B. The potential of proton beam radiation therapy in gastrointestinal cancer. Acta Oncol 2005;44(8):896-903. [More details]